AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India Limited has submitted a certificate to the stock exchange as required under SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing related to the company's depository operations and share dematerialization process. No financial figures, transaction details, or strategic changes are mentioned in the filing. Such certificates are periodically submitted by listed companies to confirm adherence to depository norms.
This is a procedural compliance filing with no material impact on shareholders, stock price, or business operations. It does not indicate any corporate action, dividend, or strategic change.